Buchumschlag

Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline‐isoxazole‐piperazine conjugates as EGFR‐targeting agents

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Mohammad Imtiyaz Ali, Narasimha Swamy Thirukovela, Gajjela Bharath Kumar, Gouthami Dasari, Vinitha Badithapuram, Ravinder Manchal, Srinivas Bandari
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Chemical Biology & Drug Design
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Design and Synthesis of New Quinoxaline‐Oxazole‐Morpholino Conjugates; Evaluation of Anticancer Activity and In Silico Molecular Docking and ADMET Studies
von: Yellaiah Bonakolluru, et al.
Veröffentlicht: (2024)

Design and Synthesis of Some New Indole‐piperazine‐1,2,3‐triazole Conjugates; In Vitro Anticancer, Molecular Docking, and ADMET Studies
von: Veeraboina Lingaswamy, et al.
Veröffentlicht: (2025)

Design and Synthesis of New Quinazoline Hybrid Molecules as EGFR Targeting Anti‐Breast Cancer Agents
von: Pandaga Saidulu, et al.
Veröffentlicht: (2026)

Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents
von: Srinuvasu Nakka, et al.
Veröffentlicht: (2024)

Novel 1,3,4‐oxadiazole derivatives of naproxen targeting EGFR: Synthesis, molecular docking studies, and cytotoxic evaluation
von: Hiba N. Alsaad, et al.
Veröffentlicht: (2024)

Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α‐glucosidase, α‐amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation
von: Ahmed Ragab, et al.
Veröffentlicht: (2024)

New Quinoxaline Linked Fused Imidazo‐oxazole Conjugates as EGFR Inhibitors: Design, Synthesis, in Vitro Anti‐Breast Cancer Evaluation, Molecular Docking Studies and in Silico ADMET
von: Mohammad Ferazoddin, et al.
Veröffentlicht: (2024)

The medicinal chemistry of piperazines: A review
von: Md Faizan, et al.
Veröffentlicht: (2024)

Exploring chromone‐2‐carboxamide derivatives for triple‐negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: Design, synthesis, and preclinical insights
von: Dalia S. El‐Gamil, et al.
Veröffentlicht: (2024)

Hydration of Nitriles to Amides under In situ Nano‐Pd Catalysis in PEG‐400
von: Mohammad Muqeed, et al.
Veröffentlicht: (2024)

Design, synthesis and characterization of ethyl 3‐benzoyl‐7‐morpholinoindolizine‐1‐carboxylate as anti‐tubercular agents: In silico screening for possible target identification
von: Priya Tiwari, et al.
Veröffentlicht: (2024)

Design, synthesis, in silico, and in vitro evaluation of novel benzyloxybenzene substituted (S)‐α‐amino amide derivatives as cholinesterases and monoaminoxidases inhibitor
von: Akın Akıncıoğlu
Veröffentlicht: (2024)

Synthesis of Fused Isoxazoles of Iodoquinol as in vitro EGFR Aiming Anticancer Agents
von: Karthik Bokkala, et al.
Veröffentlicht: (2024)

2‐Thioxo‐3,4‐dihydropyrimidine and thiourea endowed with sulfonamide moieties as dual EGFRT790M and VEGFR‐2 inhibitors: Design, synthesis, docking, and anticancer evaluations
von: Mohamed S. A. El‐Gaby, et al.
Veröffentlicht: (2024)

An integrated network pharmacology and molecular docking approach to reveal the role of Arctigenin against Cutibacterium acnes‐induced skin inflammation by targeting the CYP19A1
von: Xiaoyan Lu, et al.
Veröffentlicht: (2024)

Exploring the cytotoxic potential of biflavones of Araucaria cunninghamii: Precise identification combined by LC‐HRMS‐metabolomics and database mining, targeted isolation, network pharmacology, in vitro cytotoxicity, and docking studies
von: Bharat Sahu, et al.
Veröffentlicht: (2024)

Scopoletin Mitigates DSS‐Induced Ulcerative Colitis by Attenuating NF‐κB/MMP‐9 Mediated Inflammation and Activating the Nrf2 Pathway to Preserve Colonic Barrier Integrity
von: A Gowtham, et al.
Veröffentlicht: (2025)

In vitro and in silico investigation of FDA‐approved drugs to be repurposed against Alzheimer's disease
von: Didem Akkaya, et al.
Veröffentlicht: (2024)

Validating linalool as a potential drug for breast cancer treatment based on machine learning and molecular docking
von: Qian Zhang, et al.
Veröffentlicht: (2024)

Synthesis, docking study, and antitumor evaluation of benzamides and oxadiazole derivatives of 3‐phenoxybenzoic acid as VEGFR‐2 inhibitors
von: Mohammad H. Heriz, et al.
Veröffentlicht: (2024)

Overcoming Resistance in EGFR‐Mutant Cancers: A Comprehensive Review of Inhibitor Evolution and SAR‐Based Design
von: Hemlata Naykwadi, et al.
Veröffentlicht: (2026)

Orthoallosteric EGFR‐TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation
von: Iqrar Ahmad, et al.
Veröffentlicht: (2024)

EGFR degraders in non‐small‐cell lung cancer: Breakthrough and unresolved issue
von: Jiayi Shen, et al.
Veröffentlicht: (2024)

Synthesis and in vitro antitumor activity of galactosamine–docetaxel conjugates
von: Yongpeng Shen, et al.
Veröffentlicht: (2024)

Synthesis of Fused 1,2,3‐Triazoles of Benzimidazole Using Copper (I) Catalysis; in Vitro and in Silico Studies
von: Saidi Reddy Modugu, et al.
Veröffentlicht: (2024)

In silico optimization of analogs derived pro‐adrenomedullin peptide to evaluate antimicrobial potential
von: Raquel M. Quigua‐Orozco, et al.
Veröffentlicht: (2024)

Advanced nano-delivery systems in eradication: targeting, efficacy, and clinical translation.
von: Khan, Tehsin Ullah, et al.
Veröffentlicht: (2026)

Rational Design of Triazole Hydrazide Derivatives With Imidazo[2,1‐ b ]thiazole Scaffolds as Targeted EGFR Inhibitors in NSCLC
von: Mohamed K. Elgohary, et al.
Veröffentlicht: (2025)

Pyrimidine‐Derived Scaffolds Targeting VEGFR‐2, EGFR, and HER‐2: Synthesis, Anticancer/Immunomodulatory Evaluation, and In Silico Analysis
von: Naglaa M. Ahmed, et al.
Veröffentlicht: (2026)

Biphenylsulfonamides as effective MMP‐2 inhibitors with promising antileukemic efficacy: Synthesis, in vitro biological evaluation, molecular docking, and MD simulation analysis
von: Sandip K. Baidya, et al.
Veröffentlicht: (2024)

Design, Docking, ADMET , Pass, Synthesis and Bio‐Evaluation of Novel 7‐ O ‐Substituted Chrysin‐Based VEGFR ‐2 Inhibitors
von: Kalyani R. Thombre, et al.
Veröffentlicht: (2026)

Development of Quinoline‐Isoxazole Hybrids With Selective Cytotoxicity and EGFR Kinase Binding: In Vitro and In Silico Approaches
von: Yasemin Zeynep Şahin, et al.
Veröffentlicht: (2025)

Design, Synthesis, Biological Evaluation and Molecular Docking Study of New 1,3,4‐Thiadiazole‐Based Compounds as EGFR Inhibitors
von: Marwa I. Serag, et al.
Veröffentlicht: (2024)

Molecular Boomerangs Against Cancer: Design, Synthesis, Biological Evaluation, and In Silico Study of Novel Dual PARP‐1/EGFR Inhibitors
von: Haytham O. Tawfik, et al.
Veröffentlicht: (2026)

Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin‐4‐One Derivatives as Dual EGFR and FGFR Inhibitors
von: Sara Sultan, et al.
Veröffentlicht: (2025)

Biotin‐new indocyanine green conjugate: Synthesis, in vitro photocytotoxicity and in vivo biodistribution
von: Shengping Liu, et al.
Veröffentlicht: (2024)

DRUG POLICY: WHAT IMPACT DOES IT HAVE ON CHILDREN AND YOUTH?
von: Izabel Friche Passos
Veröffentlicht: (2013)

N‐Substituted‐5‐ [(2,5‐Dihydroxybenzyl)amino]salicylamides as Lavendustin Analogs: Antiproliferative Activity, COMPARE Analyses, Mechanistic, Docking, ADMET and Toxicity Studies
von: Hajjaj H. M. Abdu‐Allah, et al.
Veröffentlicht: (2025)

Development and evaluation of multi‐functionalized sialic acid conjugated asiatic acid nanoconstruct to mitigate cognitive deficits in Alzheimer's disease
von: Tripti Halder, et al.
Veröffentlicht: (2024)

Structural and molecular insights from dual inhibitors of EGFR and VEGFR2 as a strategy to improve the efficacy of cancer therapy
von: Krisyanti Budipramana, et al.
Veröffentlicht: (2024)